Anhui Wanbang Pharmaceutical Technology Co., Ltd. held its third board meeting, approving the acquisition of 75.52% equity in Anhui Saidesheng Pharmaceutical Technology Co., Ltd. for RMB 302.0776 million. This acquisition aims to expand the company's innovative drug R&D services and enhance its competitiveness.
Summary generated by AI · Always verify with source document
Stock Code: 301520
Stock Abbreviation: Wanbang Pharmaceutical
Announcement No.: 2026-020
Anhui Wanbang Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the Sixth Meeting of the Third Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
I. Convening of the Board Meeting
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.